GE HealthCare is trading 8.4% up at $69.51 after reporting better-than-expected second-quarter 2026 results, including higher profit and strong order growth.
- The company reaffirmed its full-year guidance and highlighted record backlog momentum following the earnings beat.
- The upward move builds on previous gains and coincides with a broader rally in healthcare stocks as investors respond to robust sector-wide performance.